Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-23

FDA Approved: EZETIMIBE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for ezetimibe submitted by Sandoz Inc, updating the approved ezetimibe product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)

Snippet

SUPPL AP for EZETIMIBE (EZETIMIBE)